Source: Virtual Congress 2021 – Artificial intelligence and big data



Rating:

Share or cite this content

Citations should be made in the following way:
L. Correia Pinheiro (London, United Kingdom). Harnessing big data for evaluation and regulation of medicines. Virtual Congress 2021 – Artificial intelligence and big data

Member's Comments

No comment yet.

Related content which might interest you: Application of big data technology for COVID-19: Primary care big data Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017 Application of management guidelines to the assessment of new medicines: driving us forward or holding us back? Source: Eur Respir J 2004; 23: 793-794 Year: 2004 Human translational medicine – phenotyping is key Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Using big data to change healthcare: improving quality of care with routine data Source: International Congress 2016 – Primary Care Day: challenging times III Year: 2016 Big data analysis in telemedicine in sleep: the European status, opportunities and pitfalls Source: Virtual Congress 2021 – Digital health meets sleep breathing disorders Year: 2021 The value proposition of medical technology: an industry perspective Source: Research Seminar 2015 - Personalising respiratory care in Europe Year: 2015 What role can medical professionals play in the development and regulation of medical technology? Source: Research Seminar 2015 - Personalising respiratory care in Europe Year: 2015 Some principles and practices of genetic biobanking studies Source: Eur Respir J 2009; 33: 419-425 Year: 2009 Exploring new frontiers: the role of simulation as an educational strategy Source: Breathe 2013; 9: 497-501 Year: 2013 Application of big data technology for COVID-19: Health economics of COVID Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 The promise of electronic data capture in respiratory medicine Source: Eur Respir J 2011; 37: 228 Year: 2011 Who can pay for innovative medicines? Source: Eur Respir J 2013; 41: 495-496 Year: 2013 Respiratory medicines for children: current evidence, unlicensed use and research priorities Source: Eur Respir J 2010; 35: 247-265 Year: 2010 Guidance production before evidence generation for critical issues: the example of COVID-19 Source: Eur Respir Rev, 29 (157) 200310; 10.1183/16000617.0310-2020 Year: 2020 Respiratory monitoring: revisiting classical physiological principles with new tools Source: Eur Respir J 2004; 24 : 718-719 Year: 2004 Traditional methods of epidemiology and how they complement what is learned from big data Source: International Congress 2019 – How do big data and classical epidemiology contribute to solving chronic respiratory ill health? Year: 2019 How to accelerate bringing new drugs to patients: role of clinical trials networks Source: International Congress 2019 – Rare lung diseases Year: 2019